These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16335853)

  • 41. Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole.
    Horn J
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():11-9. PubMed ID: 15496214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pump blockers and ulcer disease.
    Sachs G
    N Engl J Med; 1984 Mar; 310(12):785-6. PubMed ID: 6230536
    [No Abstract]   [Full Text] [Related]  

  • 43. [Changes in the treatment of peptic ulcer following the development of proton pump inhibitors].
    Takemoto T; Inamoto Y
    Nihon Rinsho; 1992 Jan; 50(1):5-10. PubMed ID: 1347329
    [No Abstract]   [Full Text] [Related]  

  • 44. Ulcer-healing drugs and endogenous prostaglandins.
    Guslandi M
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):398-402. PubMed ID: 2864318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacotherapy of acid-peptic disorders.
    Burkard PG
    Lippincotts Prim Care Pract; 1998; 2(4):398-409. PubMed ID: 9709085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Physiology of gastric acid secretion.
    Zermansky A
    Lancet; 1997 Aug; 350(9075):447. PubMed ID: 9259683
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical trial: inhibitory effect of revaprazan on gastric acid secretion in healthy male subjects.
    Kim HK; Park SH; Cheung DY; Cho YS; Kim JI; Kim SS; Chae HS; Kim JK; Chung IS
    J Gastroenterol Hepatol; 2010 Oct; 25(10):1618-25. PubMed ID: 20880169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current concepts in clinical therapeutics: peptic ulcer disease.
    Siepler JK; Mahakian K; Trudeau WT
    Clin Pharm; 1986 Feb; 5(2):128-42. PubMed ID: 2869852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Structure-function relationship of gastric proton pump].
    Asano S
    Seikagaku; 2000 Jan; 72(1):48-51. PubMed ID: 10714170
    [No Abstract]   [Full Text] [Related]  

  • 50. Helicobacter pylori and its involvement in gastritis and peptic ulcer formation.
    Konturek SJ; Konturek PC; Konturek JW; Plonka M; Czesnikiewicz-Guzik M; Brzozowski T; Bielanski W
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():29-50. PubMed ID: 17033104
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Application of Heterocycles as an Alternative for the Discovery of New Anti-ulcer Compounds: A Mini-Review.
    de Lócio LL; do Nascimento APS; Santos MB; Gomes JNS; de Medeiros E Silva YMS; Albino SL; Dos Santos VL; de Moura RO
    Curr Pharm Des; 2022; 28(17):1373-1388. PubMed ID: 35549862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The efficacy of proton-pump inhibitors in the treatment of acid-dependent diseases].
    Tkach SM
    Lik Sprava; 1997; (3):30-5. PubMed ID: 9377349
    [No Abstract]   [Full Text] [Related]  

  • 53. [Omeprazole--a drug-blocking proton pump of the parietal cells of the stomach].
    Sosnowski M
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1469-72. PubMed ID: 3008128
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effect of dalargin on the level of gastric secretion].
    Tepliuk SG
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):67-8. PubMed ID: 3801139
    [No Abstract]   [Full Text] [Related]  

  • 55. Acid rules--or does it?
    Misiewicz JJ
    J Clin Gastroenterol; 1986 Jun; 8(3 Pt 2):323-5. PubMed ID: 2876023
    [No Abstract]   [Full Text] [Related]  

  • 56. [Pharmacology of proton pump inhibitors].
    Klotz U
    Pharm Unserer Zeit; 2005; 34(3):200-4. PubMed ID: 15940952
    [No Abstract]   [Full Text] [Related]  

  • 57. Pepsins, peptic activity, and peptic inhibitors.
    Samloff IM
    J Clin Gastroenterol; 1981; 3(Suppl 2):91-4. PubMed ID: 6119339
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of peptic ulcer in the elderly. Proton pump inhibitors and histamine H2 receptor antagonists.
    Lazzaroni M; Bianchi Porro G
    Drugs Aging; 1996 Oct; 9(4):251-61. PubMed ID: 8894523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
    Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
    J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acid reduction in peptic ulcer disease. Choosing therapy according to drug interactions, individual response, and cost.
    Parent K
    Postgrad Med; 1994 Nov; 96(6):53-9. PubMed ID: 7971612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.